BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18457460)

  • 1. Guide to the use of proton pump inhibitors in adult patients.
    Boparai V; Rajagopalan J; Triadafilopoulos G
    Drugs; 2008; 68(7):925-47. PubMed ID: 18457460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.
    Yu LY; Sun LN; Zhang XH; Li YQ; Yu L; Yuan ZQ; Meng L; Zhang HW; Wang YQ
    Adv Ther; 2017 May; 34(5):1070-1086. PubMed ID: 28429247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
    Lazzaroni M; Porro GB
    Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors: use and misuse in the clinical setting.
    Savarino V; Marabotto E; Zentilin P; Furnari M; Bodini G; De Maria C; Pellegatta G; Coppo C; Savarino E
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1123-1134. PubMed ID: 30295105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.
    Richardson P; Hawkey CJ; Stack WA
    Drugs; 1998 Sep; 56(3):307-35. PubMed ID: 9777309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
    Savarino V; Di Mario F; Scarpignato C
    Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
    McKeage K; Blick SK; Croxtall JD; Lyseng-Williamson KA; Keating GM
    Drugs; 2008; 68(11):1571-607. PubMed ID: 18627213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders.
    Bardou M; Martin J; Barkun A
    Drugs; 2009; 69(4):435-48. PubMed ID: 19323587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitors: Review of Emerging Concerns.
    Nehra AK; Alexander JA; Loftus CG; Nehra V
    Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors--their pharmacological impact on the clinical management of acid-related disorders.
    Klotz U
    Arzneimittelforschung; 2009; 59(6):271-82. PubMed ID: 19634508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.
    Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG
    Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physiological background behind and course of development of the first proton pump inhibitor.
    Lundell L
    Scand J Gastroenterol; 2015 Jun; 50(6):680-4. PubMed ID: 25857639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT; Cherian S; Singh P
    Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.